Skandinaviska Enskilda Banken (SEB)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-182,821
| Closed | -$33.6M | – | 1126 |
|
2021
Q2 | $33.6M | Sell |
182,821
-104,445
| -36% | -$19.2M | 0.21% | 108 |
|
2021
Q1 | $43.9M | Sell |
287,266
-239,247
| -45% | -$36.6M | 0.29% | 81 |
|
2020
Q4 | $82.3M | Buy |
526,513
+140,098
| +36% | +$21.9M | 0.57% | 30 |
|
2020
Q3 | $44.2M | Buy |
386,415
+241,804
| +167% | +$27.7M | 0.32% | 72 |
|
2020
Q2 | $16.2M | Buy |
144,611
+31,182
| +27% | +$3.5M | 0.13% | 146 |
|
2020
Q1 | $10.2M | Sell |
113,429
-12,063
| -10% | -$1.08M | 0.1% | 185 |
|
2019
Q4 | $13.6M | Buy |
125,492
+4,685
| +4% | +$507K | 0.11% | 178 |
|
2019
Q3 | $11.8M | Sell |
120,807
-16,655
| -12% | -$1.63M | 0.1% | 190 |
|
2019
Q2 | $18M | Buy |
137,462
+9,512
| +7% | +$1.25M | 0.16% | 131 |
|
2019
Q1 | $17.3M | Sell |
127,950
-6,805
| -5% | -$920K | 0.16% | 132 |
|
2018
Q4 | $13.1M | Buy |
134,755
+3,408
| +3% | +$332K | 0.12% | 151 |
|
2018
Q3 | $18.3M | Buy |
131,347
+12,004
| +10% | +$1.67M | 0.14% | 135 |
|
2018
Q2 | $14.8M | Buy |
119,343
+9,903
| +9% | +$1.23M | 0.13% | 132 |
|
2018
Q1 | $12.2M | Sell |
109,440
-28,678
| -21% | -$3.2M | 0.12% | 130 |
|
2017
Q4 | $16.5M | Buy |
138,118
+7,778
| +6% | +$930K | 0.14% | 123 |
|
2017
Q3 | $18.3M | Sell |
130,340
-12,631
| -9% | -$1.77M | 0.17% | 116 |
|
2017
Q2 | $17.4M | Sell |
142,971
-10,600
| -7% | -$1.29M | 0.17% | 124 |
|
2017
Q1 | $18.6M | Buy |
+153,571
| New | +$18.6M | 0.19% | 108 |
|
2016
Q4 | – | Sell |
-92,820
| Closed | -$11.4M | – | 755 |
|
2016
Q3 | $11.4M | Sell |
92,820
-5,200
| -5% | -$637K | 0.12% | 136 |
|
2016
Q2 | $11.4M | Sell |
98,020
-32,200
| -25% | -$3.76M | 0.13% | 125 |
|
2016
Q1 | $18.1M | Buy |
+130,220
| New | +$18.1M | 0.2% | 90 |
|